New View Surgical

New View Surgical is a private medical device company developing and commercializing visualization and access systems for minimally invasive surgery. Its lead product, the VisionPort System, is a single-use laparoscopic imaging and access device that integrates the laparoscope, camera, light source, and access port into one instrument. The system received U.S. FDA 510(k) clearance in June 2021 and the company announced its first commercial case in December 2022. New View Surgical positions VisionPort as a surgeon-controlled platform designed to improve visualization, streamline operating-room workflow, reduce staffing needs, and lower procedural costs in minimally invasive surgery.